Bio-UV Group Reports Strong Mid-Year Financials

Bio-UV Group SA (FR:ALTUV) has released an update.

Bio-UV Group SA reported a solid performance for the first half of 2024, with an EBITDA margin rise to 17.1% and a significant increase in free cash-flow to €3.2 million. Despite a slight revenue decrease compared to the previous year, the company achieved a stable EBITDA of €3.8 million due to improved operational efficiency and reduced costs. The Group also continued its financial strategy of deleveraging, reducing its net financial debt by €3.1 million and achieving a net gearing ratio of 57%.

For further insights into FR:ALTUV stock, check out TipRanks’ Stock Analysis page.